| 3-Chloro-4-fluoro-N-[4-[[2-(phenylcarbonyl)hydrazino]carbonyl]benzyl]benzenesulfonamide |
TCN-201 |
852918-02-6 |
| Wnt Agonist |
WNT AGONIST 1 (CID11210285 盐酸盐) |
853220-52-7 |
| AUZ 454 |
K03861 |
853299-07-7 |
| ADX-47273 |
(S)-(4-氟苯基)-{3-[3-(4-氟苯基)-[1,2,4]二唑-5-基]哌啶-1-基}甲酮 |
851881-60-2 |
| VAPREOTIDE ACETATE |
849479-74-9 |
849479-74-9 |
| 5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-N-[(2S)-2-hydroxy-3-(4-morpholinyl)propyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (2Z)-2-butenedioate |
5-[(Z)-(5-氟-1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基]-N-[(2S)-2-羟基-3-(4-吗啉基)丙基]-2,4-二甲基-1H-吡咯-3-甲酰胺马来酸盐 |
849643-15-8 |
| 5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione |
(5Z)-5-[[4-(4-吡啶基)-6-喹啉基]亚甲基]-2,4-噻唑烷二酮 |
958852-01-2 |
| BTZ043 (BTZ038, BTZ044) |
BTZ043 (BTZ038, BTZ044) |
957217-65-1 |
| Pictilisib |
GDC-0941 |
957054-30-7 |
| mavatrep |
CS-1660 |
956274-94-5 |
| PD04217903 |
2-[4-[1-(喹啉-6-甲基)-1H-[1,2,3]三唑并[4,5-B]吡嗪-6-基]-1H-吡唑-1-基]乙醇 |
956905-27-4 |
| VK-II-36 |
化合物VK-II-43 |
955371-66-1 |
| N′-[3,5-Bis(trifluoromethyl)phenyl]-N-[4-bromo-2-(2H-tetrazol-5-yl)phenyl]-thiourea |
N'-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]-N-[4-BROMO-2-(2H-TETRAZOL-5-YL-PHENYL]THIOUREA |
956014-19-0 |
| ARN-509 |
阿帕鲁胺 |
956104-40-8 |
| CRT0066101 |
10MG |
956121-30-5 |
| PI-3065 |
PI-3065 |
955977-50-1 |
| 2-(2-chlorophenyl)-4-Methyl-5-(pyridin-2-ylMethyl)-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione |
AK120765 |
955272-06-7 |
| NS 11394 |
3'-[5-(1-羟基-1-甲基乙基)-1H-苯并咪唑-1-基]-[1,1'-联苯]-2-甲腈 |
951650-22-9 |
| O-(2-AMinoethyl)-O'-(2-azidoethyl)triethylene Glycol |
氨基-五聚乙二醇-叠氮 |
951671-92-4 |
| DAMGO TFA |
DAMGO (TFA) |
950492-85-0 |
